A Pitfall of the Androgen Deprivation Therapy for Salivary Duct Carcinoma: Hormonal Therapy-Induced Castrate-Resistant Prostate Cancer

被引：0
|
作者：
Shugo Yajima
Yasukazu Nakanishi
Shunya Matsumoto
Kenji Tanabe
Hitoshi Masuda
机构：
[1] National Cancer Center Hospital East,
来源：
Journal of Maxillofacial and Oral Surgery | 2022年 / 21卷
关键词：
Androgen deprivation therapy; Androgen receptors; Castration-resistant prostate cancer; Combined androgen blockade; Prostate-specific antigen; Salivary duct carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1097 / 1100
页数：3
相关论文
共 50 条
  • [41] Discovery of prostate specific antigen pattern to predict castration resistant prostate cancer of androgen deprivation therapy
    Yejin Kim
    Yong Hyun Park
    Ji Youl Lee
    In Young Choi
    Hwanjo Yu
    BMC Medical Informatics and Decision Making, 16
  • [42] Androgen Deprivation Therapy Combined With Particle Therapy for Prostate Cancer: A Systematic Review
    Petersen, Stine Elleberg
    Hoyer, Morten
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [43] Toremifene - a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy
    Taneja, SS
    Smith, MR
    Dalton, JT
    Raghow, S
    Barnette, G
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (03) : 293 - 305
  • [44] Hormonal response recovery after long-term androgen deprivation therapy in patients with prostate cancer
    Planas, Jacques
    Celma, Ana
    Placer, Jose
    Cuadras, Merce
    Regis, Lucas
    Gasanz, Carlos
    Trilla, Enrique
    Salvador, Carlos
    Lorente, David
    Morote, Juan
    SCANDINAVIAN JOURNAL OF UROLOGY, 2016, 50 (06) : 425 - 428
  • [45] Neurocognitive effects of androgen deprivation therapy and new hormonal agents in a sample of patients with metastatic prostate cancer
    Ihrig, Andreas
    Pernt, Pascal Marino
    Zschaebitz, Stefanie
    Huber, Johannes
    Friederich, Hans-Christoph
    Bugaj, Till J. J.
    Maatouk, Imad
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (11) : 2733 - 2739
  • [46] Neurocognitive effects of androgen deprivation therapy and new hormonal agents in a sample of patients with metastatic prostate cancer
    Andreas Ihrig
    Pascal Marino Pernt
    Stefanie Zschäbitz
    Johannes Huber
    Hans-Christoph Friederich
    Till J. Bugaj
    Imad Maatouk
    International Urology and Nephrology, 2023, 55 : 2733 - 2739
  • [47] Clinical implications for a treatment algorithm and differential indication to hormone therapy and chemotherapy options in metastatic castrate-resistant prostate cancer: a personal view
    Bracarda, Sergio
    Sisani, Michele
    Marrocolo, Francesca
    Hamzaj, Alketa
    Del Buono, Sabrina
    Altavilla, Amelia
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (11) : 1283 - 1294
  • [48] Dynamics in the Prostate Immune Microenvironment Induced by Androgen Deprivation Therapy
    Yanai, Yoshinori
    Kosaka, Takeo
    Mikami, Shuji
    Arai, Masashi
    Watanabe, Keitaro
    Takeda, Toshikazu
    Matsumoto, Kazuhiro
    Yamashita, Makiko
    Kitano, Shigehisa
    Oya, Mototsugu
    PROSTATE, 2025, 85 (03) : 308 - 314
  • [49] Cardiometabolic side effects of androgen deprivation therapy in prostate cancer
    Lafontaine, Marie-Lyssa
    Kokorovic, Andrea
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2022, 16 (04) : 216 - 222
  • [50] Metabolic sequelae associated with androgen deprivation therapy for prostate cancer
    Faris, Jason E.
    Smith, Matthew R.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2010, 17 (03) : 240 - 246
12345